Fecal Fungal Microbiota (Mycobiome) Study as a Potential Tool for Precision Medicine in Inflammatory Bowel Disease

키워드

참고문헌 (88)

1. Chang JT, "Pathophysiology of inflammatory bowel diseases", N Engl J Med, 383, pp.2652~2664 (2020)
2. de Souza HS, "Immunopathogenesis of IBD : current state of the art", Nat Rev Gastroenterol Hepatol, 13, pp.13~27 (2016)
3. de Souza HS, "The IBD interactome : an integrated view of aetiology, pathogenesis and therapy", Nat Rev Gastroenterol Hepatol, 14, pp.739~749 (2017)
4. Cani PD, "Human gut microbiome : hopes, threats and promises", Gut, 67, pp.1716~1725 (2018)
5. Schirmer M, "Microbial genes and pathways in inflammatory bowel disease", Nat Rev Microbiol, 17, pp.497~511 (2019)
6. Nishida A, "Gut microbiota in the pathogenesis of inflammatory bowel disease", Clin J Gastroenterol, 11, pp.1~10 (2018)
7. Liu S, "The microbiome in inflammatory bowel diseases : from pathogenesis to therapy", Protein Cell, 12, pp.331~345 (2021)
8. Oka A, "Microbial-based and microbial-targeted therapies for inflammatory bowel diseases", Dig Dis Sci, 65, pp.757~788 (2020)
9. Iliev ID, "Effects of intestinal fungi and viruses on immune responses and inflammatory bowel diseases", Gastroenterology, 160, pp.1050~1066 (2021)
10. Richard ML, "Gut fungal microbiota : the Yin and Yang of inflammatory bowel disease", Inflamm Bowel Dis, 21, pp.656~665 (2015)
11. Miyoshi J, "The evidence for fungus in Crohn’s disease pathogenesis", Clin J Gastroenterol, 11, pp.449~456 (2018)
12. Azevedo MM, "The effect of antibacterial and non-antibacterial compounds alone or associated with antifugals upon fungi", Front Microbiol, 6, pp.669~ (2015)
13. Kapitan M, "Fungi as part of the microbiota and interactions with intestinal bacteria", Curr Top Microbiol Immunol, 422, pp.265~301 (2019)
14. Hoarau G, "Bacteriome and mycobiome interactions underscore microbial dysbiosis in familial Crohn’s disease", mBio, 7, pp.e01250~16 (2016)
15. Sokol H, "Fungal microbiota dysbiosis in IBD", Gut, 66, pp.1039~1048 (2017)
16. Gu Y, "The potential role of gut mycobiome in irritable bowel syndrome", Front Microbiol, 10, pp.1894~ (2019)
17. Zuo T, "Gut fungal dysbiosis correlates with reduced efficacy of fecal microbiota transplantation in Clostridium difficile infection", Nat Commun, 9, pp.3663~ (2018)
18. Bajaj JS, "Fungal dysbiosis in cirrhosis", Gut, 67, pp.1146~1154 (2018)
19. Coker OO, "Enteric fungal microbiota dysbiosis and ecological alterations in colorectal cancer", Gut, 68, pp.654~662 (2019)
20. Qin J, "A human gut microbial gene catalogue established by metagenomic sequencing", Nature, 464, pp.59~65 (2010)
21. Limon JJ, "Commensal fungi in health and disease", Cell Host Microbe, 22, pp.156~165 (2017)
22. Kappe R, "Universal fungus-specific primer systems and group-specific hybridization oligonucleotides for 18S rDNA", Mycoses, 39, pp.25~30 (1996)
23. Chin VK, "Mycobiome in the gut : a multiperspective review", Mediators Inflamm, 2020, pp.9560684~ (2020)
24. Li Q, "Dysbiosis of gut fungal microbiota is associated with mucosal inflammation in Crohn's disease", J Clin Gastroenterol, 48, pp.513~523 (2014)
25. Chehoud C, "Fungal signature in the gut microbiota of pediatric patients with inflammatory bowel disease", Inflamm Bowel Dis, 21, pp.1948~1956 (2015)
26. Guslandi M, "Saccharomyces boulardii in maintenance treatment of Crohn’s disease", Dig Dis Sci, 45, pp.1462~1464 (2000)
27. Zwolinska-Wcislo M, "Effect of Candida colonization on human ulcerative colitis and the healing of inflammatory changes of the colon in the experimental model of colitis ulcerosa", J Physiol Pharmacol, 60, pp.107~118 (2009)
28. Leonardi I, "Fungal trans-kingdom dynamics linked to responsiveness to fecal microbiota transplantation(FMT)therapy in ulcerative colitis", Cell Host Microbe, 27, pp.823~829 (2020)
29. Ventin-Holmberg R, "Bacterial and fungal profiles as markers of infliximab drug response in inflammatory bowel disease", J Crohns Colitis, 15, pp.1019~1031 (2021)
30. Raine T, "Breaking through the therapeutic ceiling : what will it take?", Gastroenterology, 162, pp.1507~1511 (2022)
31. Fiocchi C, "Results of the Seventh Scientific Workshop of ECCO : precision medicine in IBD : what, why, and how", J Crohns Colitis, 15, pp.1410~1430 (2021)
32. Schleidgen S, "What is personalized medicine : sharpening a vague term based on a systematic literature review", BMC Med Ethics, 14, pp.55~ (2013)
33. Torres J, "Results of the Seventh Scientific Workshop of ECCO : precision medicine in IBD : prediction and prevention of inflammatory bowel disease", J Crohns Colitis, 15, pp.1443~1454 (2021)
34. Santana PT, "Dysbiosis in inflammatory bowel disease : pathogenic role and potential therapeutic targets", Int J Mol Sci, 23, pp.3464~ (2022)
35. Nilsson RH, "Taxonomic reliability of DNA sequences in public sequence databases : a fungal perspective", PLoS One, 1, pp.e59~ (2006)
36. Huffnagle GB, "The emerging world of the fungal microbiome", Trends Microbiol, 21, pp.334~341 (2013)
37. Nash AK, "The gut mycobiome of the Human Microbiome Project healthy cohort", Microbiome, 5, pp.153~ (2017)
38. Arumugam M, "Enterotypes of the human gut microbiome", Nature, 473, pp.174~180 (2011)
39. Evans CC, "Exercise prevents weight gain and alters the gut microbiota in a mouse model of high fat diet-induced obesity", PLoS One, 9, pp.e92193~ (2014)
40. Misic AM, "The shared microbiota of humans and companion animals as evaluated from Staphylococcus carriage sites", Microbiome, 3, pp.2~ (2015)
41. David LA, "Diet rapidly and reproducibly alters the human gut microbiome", Nature, 505, pp.559~563 (2014)
42. Strati F, "Age and gender affect the composition of fungal population of the human gastrointestinal tract", Front Microbiol, 7, pp.1227~ (2016)
43. Liguori G, "Fungal dysbiosis in mucosa-associated microbiota of Crohn’s disease patients", J Crohns Colitis, 10, pp.296~305 (2016)
44. Hallen-Adams HE, "Fungi in the healthy human gastrointestinal tract", Virulence, 8, pp.352~358 (2017)
45. Fischer JC, "RIG-I", MAVS and STING signaling promote gut integrity during irradiation-and immune-mediated tissue injury, 2017, pp.9, eaag2513~
46. Hoffmann C, "Archaea and fungi of the human gut microbiome : correlations with diet and bacterial residents", PLoS One, 8, pp.e66019~ (2013)
47. Fiers WD, "Gut mycobiota under scrutiny : fungal symbionts or environmental transients?", Curr Opin Microbiol, 50, pp.79~86 (2019)
48. Li J, "Fungi in gastrointestinal tracts of human and mice : from community to functions", Microb Ecol, 75, pp.821~829 (2018)
49. Leonardi I, "Mucosal fungi promote gut barrier function and social behavior via type 17 immunity", Cell, 185, pp.831~846 (2022)
50. Nel Van Zyl K, "The effect of storage conditions on microbial communities in stool", PLoS One, 15, pp.e0227486~ (2020)
51. Jones J, "Fecal sample collection methods and time of day impact microbiome composition and short chain fatty acid concentrations", Sci Rep, 11, pp.13964~ (2021)
52. Fiedorová K, "The impact of DNA extraction methods on stool bacterial and fungal microbiota community recovery", Front Microbiol, 10, pp.821~ (2019)
53. Schoch CL, "Nuclear ribosomal internal transcribed spacer(ITS)region as a universal DNA barcode marker for Fungi", Proc Natl Acad Sci U S A, 109, pp.6241~6246 (2012)
54. Wiesmann C, "Primers matter : influence of the primer selection on human fungal detection using high throughput sequencing", Gut Microbes, 14, pp.2110638~ (2022)
55. Lücking R, "Unambiguous identification of fungi : where do we stand and how accurate and precise is fungal DNA barcoding?", IMA Fungus, 11, pp.14~ (2020)
56. Mbareche H, "Comparison of the performance of ITS1 and ITS2 as barcodes in amplicon-based sequencing of bioaerosols", PeerJ, 8, pp.e8523~ (2020)
57. Ranjan R, "Analysis of the microbiome : advantages of whole genome shotgun versus 16S amplicon sequencing", Biochem Biophys Res Commun, 469, pp.967~977 (2016)
58. Blanco-Míguez A, "Extending and improving metagenomic taxonomic profiling with uncharacterized species using MetaPhlAn 4", Nat Biotechnol (2023)[DOI]
59. Donovan PD, "Identification of fungi in shotgun metagenomics datasets", PLoS One, 13, pp.e0192898~ (2018)
60. McMurdie PJ, "Waste not, want not : why rarefying microbiome data is inadmissible", PLoS Comput Biol, 10, pp.e1003531~ (2014)
61. Nearing JT, "Microbiome differential abundance methods produce different results across 38 datasets", Nat Commun, 13, pp.342~ (2022)
62. Pollock J, "The madness of microbiome : attempting to find consensus"best practice"for 16S microbiome studies", Appl Environ Microbiol, 84, pp.e02627~17 (2018)
63. Carvalho A, "Dectin-1 isoforms contribute to distinct Th1", Th17 cell activation in mucosal candidiasis, 2012, pp.9, 276~286
64. Iliev ID, "Interactions between commensal fungi and the C-type lectin receptor Dectin-1influence colitis", Science, 336, pp.1314~1317 (2012)
65. LeibundGut-Landmann S, "Sykand CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17", Nat Immunol, 8, pp.630~638 (2007)
66. Jain U, "Debaryomyces is enriched in Crohn’s disease intestinal tissue and impairs healing in mice", Science, 371, pp.1154~1159 (2021)
67. Beaudoin M, "Deep resequencing of GWAS loci identifies rare variants in CARD9, IL23R and RNF186 that are associated with ulcerative colitis", PLoS Genet, 9, pp.e1003723~ (2013)
68. Limon JJ, "Malassezia is associated with Crohn’s disease and exacerbates colitis in mouse models", Cell Host Microbe, 25, pp.377~388 (2019)
69. Standaert-Vitse A, "Candida albicans colonization and ASCA in familial Crohn’s disease", Am J Gastroenterol, 104, pp.1745~1753 (2009)
70. Annese V, "Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease : comparison of different assays and correlation with clinical features", Aliment Pharmacol Ther, 20, pp.1143~1152 (2004)
71. Torres J, "Serum biomarkers identify patients who will develop inflammatory bowel diseases up to 5 years before diagnosis", Gastroenterology, 159, pp.96~104 (2020)
72. Ott SJ, "Fungi and inflammatory bowel diseases : alterations of composition and diversity", Scand J Gastroenterol, 43, pp.831~841 (2008)
73. Bacher P, "Human anti-fungal Th17 immunity and pathology rely on cross-reactivity against Candida albicans", Cell, 176, pp.1340~1355 (2019)
74. Nelson A, "The impact of NOD2 genetic variants on the gut mycobiota in Crohn’s disease patients in remission and in individuals without gastrointestinal inflammation", J Crohns Colitis, 15, pp.800~812 (2021)
75. Lemoinne S, "Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis", Gut, 69, pp.92~102 (2020)
76. Lewis JD, "Inflammation, antibiotics, and diet as environmental stressors of the gut microbiome in pediatric Crohn’s disease", Cell Host Microbe, 22, pp.247~ (2017)
77. Imai T, "Characterization of fungal dysbiosis in Japanese patients with inflammatory bowel disease", J Gastroenterol, 54, pp.149~159 (2019)
78. Qiu X, "Characterization of fungal and bacterial dysbiosis in young adult Chinese patients with Crohn’s disease", Therap Adv Gastroenterol, 13, pp.1756284820971202~ (2020)
79. Zeng L, "Fecal fungal microbiota alterations associated with clinical phenotypes in Crohn’s disease in southwest China", PeerJ, 10, pp.e14260~ (2022)
80. Mukhopadhya I, "The fungal microbiota of de-novo paediatric inflammatory bowel disease", Microbes Infect, 17, pp.304~310 (2015)
81. El Mouzan MI, "Fungal dysbiosis predicts the diagnosis of pediatric Crohn’s disease", World J Gastroenterol, 24, pp.4510~4516 (2018)
82. Catalàn-Serra I, "P712 Fungal microbiota composition in Inflammatory Bowel Disease patients in a Norwegian cohort : characterization of disease phenotypes and correlation with clinical activity and disease course", J Crohns Colitis, 16(Suppl 1), pp.i608~i609 (2022)
83. Wright EK, "Microbial factors associated with postoperative Crohn’s disease recurrence", J Crohns Colitis, 11, pp.191~203 (2017)
84. Buisson A, "Role of adherent and invasive Escherichia coli in Crohn’s disease : lessons from the postoperative recurrence model", Gut, 72, pp.39~48 (2023)
85. Bou Ghanem EN, "InlA promotes dissemination of Listeria monocytogenes to the mesenteric lymph nodes during food borne infection of mice", PLoS Pathog, 8, pp.e1003015~ (2012)
86. Xie J, "Zinc supplementation reduces Candida infections in pediatric intensive care unit : a randomized placebo-controlled clinical trial", J Clin Biochem Nutr, 64, pp.170~173 (2019)
87. Ghannoum MA, "Evaluation of microbiome alterations following consumption of BIOHM, a novel probiotic", Curr Issues Mol Biol, 43, pp.2135~2146 (2021)
88. Kristensen VA, "Inflammatory bowel disease in South-Eastern Norway III(IBSEN III) : a new population-based inception cohort study from South-Eastern Norway", Scand J Gastroenterol, 56, pp.899~905 (2021)

관련 논문AI추천